Department of Psychiatry, Weill Cornell Medicine, New York, New York
2Articles
2.1KReads1
2025–2026Active
4Collaborators
1Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Benjamin D. Brody, MD, is affiliated with the Department of Psychiatry at Weill Cornell Medicine in New York. His publications focus on the psychopharmacology of treatments for major depressive disorder, including ketamine and psychedelics, as well as issues related to suicide. Brody's work has appeared in Psychiatrist.com between 2025 and 2026, often collaborating with co-authors such as Ben Everett and Dennis M. Popeo.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
